Shandong Xinhua Pharmaceutical Company Limited Capital Reinvestment Ratio
Shandong Xinhua Pharmaceutical Company Limited capital reinvestment ratio. Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Capital Reinvestment Ratio of 1.44x as of September 2023, meaning it reinvests 1% of its operating cash flow (€56.11 Million) in capital expenditures (€80.69 Million). See Shandong Xinhua Pharmaceutical Company L (XIN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Capital reinvestment ratio of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. This chart tracks Shandong Xinhua Pharmaceutical Company Limited's Capital Reinvestment Ratio across 13 annual periods. See Shandong Xinhua Pharmaceutical Company L (XIN) flexibility index to measure the company's free cash flow as a share of total liabilities.
Shandong Xinhua Pharmaceutical Company Limited Capital Reinvestment Ratio by Year (2013–2025)
Shandong Xinhua Pharmaceutical Company Limited capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see Shandong Xinhua Pharmaceutical Company L cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | €533.73 Million | €115.60 Million | ▼ -62.5% |
| 2024 | 0.58x | €367.61 Million | €212.42 Million | ▼ -52.9% |
| 2023 | 1.23x | €265.28 Million | €325.13 Million | ▲ +279.7% |
| 2022 | 0.32x | €758.24 Million | €244.76 Million | ▼ -66.4% |
| 2021 | 0.96x | €259.12 Million | €249.23 Million | ▲ +44.2% |
| 2020 | 0.67x | €420.19 Million | €280.19 Million | ▼ -36.6% |
| 2019 | 1.05x | €348.27 Million | €366.51 Million | ▼ -12.2% |
| 2018 | 1.20x | €323.91 Million | €388.44 Million | ▲ +79.1% |
| 2017 | 0.67x | €389.97 Million | €261.11 Million | ▲ +29.6% |
| 2016 | 0.52x | €439.35 Million | €227.07 Million | ▲ +6.6% |
| 2015 | 0.48x | €348.64 Million | €169.09 Million | ▼ -35.4% |
| 2014 | 0.75x | €346.34 Million | €260.17 Million | ▼ -77.1% |
| 2013 | 3.28x | €104.99 Million | €344.53 Million | — |